Cargando…
Neoadjuvant Four-Drug Combination Therapy for NSCLC With EGFR Mutation Avoiding Total Pneumonectomy
We report a case of successful neoadjuvant four-drug combination therapy to avoid total pneumonectomy. A 33-year-old male patient was diagnosed with locally advanced non-squamous NSCLC harboring EGFR mutation in the left lower lobe. The patient experienced significant clinical downstaging after two...
Autores principales: | Li, Jingpei, Xu, Ke, Cai, Weipeng, Zhang, Yalei, Zeng, Xin, Cui, Fei, Hao, Zhexue, Liu, Jun, He, Jianxing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378529/ https://www.ncbi.nlm.nih.gov/pubmed/32766151 http://dx.doi.org/10.3389/fonc.2020.01145 |
Ejemplares similares
-
Erratum: Neoadjuvant Four-Drug Combination Therapy for NSCLC With EGFR Mutation Avoiding Total Pneumonectomy
Publicado: (2020) -
Neoadjuvant EGFR-TKI Therapy for EGFR-Mutant NSCLC: A Systematic Review and Pooled Analysis of Five Prospective Clinical Trials
por: Sun, Li, et al.
Publicado: (2021) -
Video-assisted thoracoscopic surgery for primary lung cancer resections in patients with moderate to severe chronic obstructive pulmonary diseases
por: Xu, Ke, et al.
Publicado: (2021) -
Morbidity and mortality after pneumonectomy in smokers with NSCLC
por: Kirschbaum, Andreas, et al.
Publicado: (2008) -
Continuous Vaginal Bleeding Induced By EGFR-TKI in Premenopausal Female Patients With EGFR Mutant NSCLC
por: Yu, Min, et al.
Publicado: (2022)